Plan Carefully In Writing Combo Product Designation Requests, Experts Say
This article was originally published in The Gray Sheet
Companies need to carefully consider tactics for ensuring proper regulation of combination products, including looking at whether a manufacturer really needs a formal request for designation, say industry and legal experts.
You may also be interested in...
FDA's Jeffrey Shuren and Janet Woodcock tell a Senate committee that the agency is more concerned with implementing combination product provisions from the 21st Century Cures Act than working on a novel review pathway for device/drug combination products.
FDA's "primary-mode-of-action" 1final rule for combination products largely mirrors the language of last year's proposed version, although the agency adds clarification on various issues raised by stakeholders
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.